Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB–inducing kinase while activating both canonical and alternative nuclear factor-κB pathways by Lan V. Pham, Lingchen Fu, Archito T. Tamayo, Carlos Bueso-Ramos, Elias Drakos, Francisco Vega, L. Jeffrey Medeiros, and Richard J. Ford Blood Volume 117(1):200-210 January 6, 2011 ©2011 by American Society of Hematology Identification and characterization of NF-κB family members in DLBCL subsets. Lan V. Pham et al. Blood 2011;117:200-210 ©2011 by American Society of Hematology Immunohistochemical analysis of NF-κB components in DLBCL cell lines and primary DLBCL samples. Lan V. Pham et al. Blood 2011;117:200-210 ©2011 by American Society of Hematology NF-kB DNA-binding analysis in DLBCL cell lines and primary samples. Lan V. Pham et al. Blood 2011;117:200-210 ©2011 by American Society of Hematology NIK kinase protein accumulates in DLBCL tumor cells. Lan V. Pham et al. Blood 2011;117:200-210 ©2011 by American Society of Hematology BR3 receptor activation promotes DLBCL cell growth through NIK protein stabilization. Lan V. Pham et al. Blood 2011;117:200-210 ©2011 by American Society of Hematology The role of TRAF3 in the stabilization of NIK in DLBCL cells. Lan V. Pham et al. Blood 2011;117:200-210 ©2011 by American Society of Hematology Constitutive BLyS/BR3 signaling activates NIK-induced NF-κB pathway activation through induction of TRAF3 degradation in DLBCL. (A) Cytoplasmic cell lysates from MS-GCB or HBABC DLBCL cells were immunoprecipitated with BR3 or TRAF3 antibodies and probed wi... Lan V. Pham et al. Blood 2011;117:200-210 ©2011 by American Society of Hematology